$ATRX Adhera is developing MLR-1023 (tolimidone) as a new drug for Type I diabetes with a focus on C-peptide positive patients. $PFE Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.